APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy
about
Emerging roles of lactic acid bacteria in protection against colorectal cancerTargeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancerA Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunitiesInflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.Salinomycin inhibited cell proliferation and induced apoptosis in human uterine leiomyoma cells.Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressorCytoprotective effects of IAPs revealed by a small molecule antagonist.Biological determinants of radioresistance and their remediation in pancreatic cancer.Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanismsDown-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis.Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.
P2860
Q24563783-4F6D9432-31C8-46AE-A62B-F0B29C734A3DQ28659468-798715FF-225C-4685-B94E-53E5727B05F4Q33515420-65542292-5F66-4D68-8A90-B80CB26945F6Q34139691-43BE58F6-A26C-49F9-B4A2-A93C0730B9BEQ34450860-1C6F3AD9-7AEC-4350-8935-837DE6BC580CQ34577035-062B36D5-C569-43FD-9289-493C236110A7Q35025461-791ECCE4-7DE5-45FD-8795-0819FEA53EB0Q35951377-13762155-C3A5-4DA3-BA99-E942126C417AQ37172657-91B4A07B-B6F2-449C-A847-7A983052B981Q39156722-4327A41D-EED5-441D-A8A9-B060D3013B5EQ39195907-CFABA077-D092-4F2F-9CDD-40C57EF5F930Q41532348-953A92A9-C7AA-4070-9F2B-F4971634C544Q42632400-CD5709FD-20BE-47C0-A8B3-972963DEDAA5
P2860
APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@ast
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@en
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@nl
type
label
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@ast
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@en
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@nl
prefLabel
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@ast
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@en
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@nl
P2093
P1476
APO2 ligand/tumor necrosis fac ...... and in prostate cancer therapy
@en
P2093
Alexandru Almasan
Maria Cristina Bucur
Octavian Bucur
Subrata Ray
P304
P407
P577
2006-05-01T00:00:00Z